Reinventing Pharmaceutical Sales Forces (PH127)
-
CLICK TO DOWNLOAD
- Published 2009
- 141 Pages
- 500+ Metrics
- 90+ Charts and Diagrams
-
Rework your pharma sales force practices to reach and influence targets
The "more is better" methodology of selling is dead. The Wall Street Journal now predicts that the number of pharmaceutical sales reps in the US will drop to 70,000 by the year 2015. This is a tremendous change from the boom of the 1990s and early 2000s, when the total number of reps exceeded 100,000.
While some companies began adapting a few years ago, other companies now find themselves well behind. For those organizations trying to evolve, reducing pharma sales force mirroring, creating more personal relationships with targets, and uncovering new ways to reach physicians are the orders of the day. The companies that will excel will be those that innovate now and find new avenues for connecting with targets.

Sales Force Models and Trends
Cutting Edge Information's Reinventing Pharmaceutical Sales Forces analyzes the current state of the pharmaceutical sales model and reveals how innovative leaders are winning in a time when most companies find themselves in trouble.
The report makes its case with metrics and methodologies for preparing pharma sales forces to compete now and into the future. The report covers three main areas:
- Incorporating eDetailing and Closed Loop Marketing — Examines some of the newest ways pharmaceutical sales forces are reaching physicians and meeting targets' specific needs.
- New Field Force Tactics — Studies the "new look" field force, which values one-on-one relationships between doctor and rep, fewer reps per district manager, a more technologically equipped team and increased rep accountability.
- Structures, Budgets and Sales Staff Compensation — Analyzes the sales force investment levels and resource allocations of today. The chapter also reveals compensation levels of newly hired, average and high-performing reps, district managers and regional managers.
-
Companies Included in Pharmaceutical Sales Management Research
- Abbott Laboratories
- Amgen
- Amylin
- Astellas
- Auriga Labs
- Axcan Pharma
- Barr
- Bayer Healthcare
- Baxter
- Boehringer-Ingelheim
- Bristol-Myers Squibb
- Centocor-Ortho Biotech
- Cubist
- GlaxoSmithKline
- Johnson & Johnson
- MedImmune
- Merck
- Novartis
- Novo Nordisk
- Ortho-McNeil
- Pfizer
- Purdue Pharma
- Quinnova Pharmaceuticals
- Schering-Plough
- Solvay Pharmaceuticals
- Somaxon Pharmaceuticals
- Sucampo Pharmaceutical
- Teva
- Wyeth
- ... plus more
-
Pharmaceutical Sales Management Metrics
Pharmaceutical Competitive Intelligence contains the following metrics. Please note that this list does not include all data, but is instead intended to give an overview of the information within the report.
Back to TopChapter 1: Incorporating eDetailing and Closed-Loop Marketing
eDetailing:
- eDetailing program investment
- Percentage of eDetailing investment outsourced
- Percentage of companies measuring ROI on eDetailing
- Percentage of total eDetails delivered by type
- Percentage of the eDetailing budget dedicated to each type
- Total dollars spent by type of eDetail
- Rating the effectiveness of eDetailing types
- Ideal lifecycle stage for eDetailing campaigns
- Level of prescribers targeted by eDetailing
- Dedicated eDetailing teams
- Dedicated eDetailing team annual budgets
- Investment per Dedicated eDetailing team member
- eDetailing types performed by dedicated eDetailing teams
- Percentage of dedicated eDetailing teams' budgets spent by eDetailing type
- eDetailing delivery methodology for dedicated eDetailing teams
Customer Relationship Management (CRM) and Closed-Loop Marketing Systems:
- Percentage of companies using a CRM system
- Percentage of companies using a closed-loop marketing system
- Percentage of companies investigating the installation of closed-loop marketing systems
- Investment in closed-loop marketing systems
Chapter 2: New Age Field Force Tactics
- Overall changes to district manager to rep ratios over the past 12 to 24 months
- Impact of sales force contraction on rep to district manager ratios
- Impact of sales force expansion on rep to district manager ratios
- Average number of reps targeting each level of physician - broken down by primary care sales and specialty/hospital sales
- Mirroring for top- , mid- and low-level targets - primary care sales and specialty/hospital sales
- Shifts in the average number of target visits attempted daily by sales reps over the last 12 to 24 months
- Impact of contraction on the number of visits attempted and drugs carried -- primary reps and specialty/hospital reps
- Impact of the January 2009 changes to the PhRMA Code
Maximizing Sales Rep Success:
- Metrics gauge the success rate and amount of time -- by percentage and by average number of minutes -- that primary care reps and specialty/hospital reps are able to spend detailing physicians. Current year data and 2007 data are shown.
- Using total office calls to find key influencers
Chapter 3: Structures, Budgets and Sales Staff Compensation
Sales Force Contraction Data:
- Percentage by which expanding pharmaceutical sales forces grew over the last 12 to 24 months
- Percentage by which contracting sales forces shrank over the last 12 to 24 months
- Sales force expansion/contraction planned over the next 12 to 24 months
- Sales force realignments
Sales Force Investments:
- Total annual pharmaceutical sales force investment
- Total annual sales force investment per rep
- Average annual cost - per primary care sales rep and per specialty/hospital rep
- Average resource allocation - per primary care sales force and per specialty/hospital sales force
- Cost per detail - primary care sales and specialty/hospital sales
Sales Staff Compensation:
- Section contains compensation data for primary care and specialty/hospital reps and district managers and regional managers across the performance spectrum.
-
Pharmaceutical Sales Management Report Sample
The following excerpt is taken from Chapter 1, "Incorporating eDetailing and Closed-Loop Marketing," section 2: "Customer Relationship Management and Closed-Loop Marketing System." The complete report provides full details on emerging sales tools.
With the pharmaceutical sales arms race now officially over and even reversing course, companies that help their reps stand out among those left in the field will earn the types of close-knit relationships with doctors for which everyone yearns. Sales leaders must deploy a knowledgeable, engaging and well-equipped force.
One way that companies can ensure that their reps stand out from the crowd is by installing and running customer relationship management systems as well as closed-loop marketing systems.
CRM Systems
Many companies have customer relationship management systems in place. As shown in Figure 1.22 [data shown in full report], 59.5% of companies surveyed now own CRM tools. CRM systems help companies identify which doctors to call on, how often to call on them and when it is time to visit them. CRM systems also allow pharmaceutical companies to capture all points of communication between customers and the company, including when doctors phone call centers, receive marketing materials, visit Web content or seek out help at conventions.
With this data, companies can manage all channels of contact with the target and connect them. So, for instance, if a doctor goes to a convention and requests something from a company representative at the convention, that person would upload the request into the CRM and the CRM system would send that doctors rep an email informing them of the request.
With CRM systems in place at virtually all of the top pharmaceutical companies and many of the mid-level companies, adding a closed-loop marketing system to coincide with a CRM application will bring the next generation of service and improve pharmaceutical sales forces' efforts tremendously...
The following excerpt is taken from Chapter 2, "New Age Field Force Tactics," section 2, "Maximizing Sales Rep Success." The full report examines strategies and tactics of the "new look" field force.
Best Practices for In-Office Interactions
One of the most interesting trends emerging in the field today is the cross-training of reps on managed care and market access issues. With this knowledge, reps are assisting doctors to get reimbursement for their patients and navigate what can be confusing formularies of their clients. Reps also relay the latest market access changes regularly to make doctors aware of evolving market access situations.
Physicians focus on getting the right medicines to their patients and do not have enough time to keep track of every formulary change across the numerous insurance plans of their patients. Sales reps can - and should — keep their targets up-to-date on changes that affect their brands. This added level of service is something that the next generation of sales rep will have to do to stay competitive.
At one interviewed company, this service helped maintain market share when one of the company's products dropped a tier on a major formulary. At this company, sales reps preemptively communicated the change to targets but also told physicians that the company was providing rebates to cover the difference in patient costs. This assured doctors that leaving their patients on the same treatment regimen would not hurt customers' pocketbooks.
In the future, as the US moves more and more toward socialized medicine, reps will need to understand and communicate managed care and market access information...
Back to Top







